143 related articles for article (PubMed ID: 37016331)
21. Prognostic impact of surgery for early-stage invasive breast cancer on breast cancer-specific survival, overall survival, and recurrence risk: a population-based analysis.
Thöne K; Rudolph A; Obi N; Chang-Claude J; Flesch-Janys D
Breast Cancer Res Treat; 2018 Jul; 170(2):381-390. PubMed ID: 29556781
[TBL] [Abstract][Full Text] [Related]
22. Circulating lipids and breast cancer prognosis in the Malmö diet and cancer study.
Harborg S; Ahern TP; Feldt M; Rosendahl AH; Cronin-Fenton D; Melander O; Borgquist S
Breast Cancer Res Treat; 2022 Feb; 191(3):611-621. PubMed ID: 34825306
[TBL] [Abstract][Full Text] [Related]
23. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
25. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer.
Caan BJ; Kwan ML; Hartzell G; Castillo A; Slattery ML; Sternfeld B; Weltzien E
Cancer Causes Control; 2008 Dec; 19(10):1319-28. PubMed ID: 18752034
[TBL] [Abstract][Full Text] [Related]
26. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
[TBL] [Abstract][Full Text] [Related]
27. Patient Characteristics and Outcomes of Nonmetastatic Breast Cancer in Haiti: Results from a Retrospective Cohort.
Fadelu T; Damuse R; Lormil J; Pecan E; Dubuisson C; Pierre V; Rebbeck T; Shulman LN
Oncologist; 2020 Sep; 25(9):e1372-e1381. PubMed ID: 32584461
[TBL] [Abstract][Full Text] [Related]
28. Circulating tumour cells in non-metastatic breast cancer: a prospective study.
Lucci A; Hall CS; Lodhi AK; Bhattacharyya A; Anderson AE; Xiao L; Bedrosian I; Kuerer HM; Krishnamurthy S
Lancet Oncol; 2012 Jul; 13(7):688-95. PubMed ID: 22677156
[TBL] [Abstract][Full Text] [Related]
29. Plasma carotenoids and recurrence-free survival in women with a history of breast cancer.
Rock CL; Flatt SW; Natarajan L; Thomson CA; Bardwell WA; Newman VA; Hollenbach KA; Jones L; Caan BJ; Pierce JP
J Clin Oncol; 2005 Sep; 23(27):6631-8. PubMed ID: 16170170
[TBL] [Abstract][Full Text] [Related]
30. Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer.
Roy-Luzarraga M; Abdel-Fatah T; Reynolds LE; Clear A; Taylor JG; Gribben JG; Chan S; Jones L; Hodivala-Dilke K
JAMA Netw Open; 2020 Oct; 3(10):e2019304. PubMed ID: 33107920
[TBL] [Abstract][Full Text] [Related]
31. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
[No Abstract] [Full Text] [Related]
32. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study.
Kwan ML; Kushi LH; Weltzien E; Tam EK; Castillo A; Sweeney C; Caan BJ
J Clin Oncol; 2010 Oct; 28(29):4410-6. PubMed ID: 20805458
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with trastuzumab.
Blanchette PS; Desautels DN; Pond GR; Bartlett JMS; Nofech-Mozes S; Yaffe MJ; Pritchard KI
Breast Cancer Res Treat; 2018 Jul; 170(1):169-177. PubMed ID: 29520532
[TBL] [Abstract][Full Text] [Related]
34. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
Resende U; Cabello C; Ramalho SOB; Zeferino LC
BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer.
Andersen HH; Bojesen SE; Johansen JS; Ejlertsen B; Berg T; Tuxen M; Madsen K; Danø H; Flyger H; Jensen MB; Nielsen DL
Cancer Epidemiol Biomarkers Prev; 2024 May; 33(5):662-670. PubMed ID: 38358318
[TBL] [Abstract][Full Text] [Related]
36. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
Tie J; Cohen JD; Wang Y; Christie M; Simons K; Lee M; Wong R; Kosmider S; Ananda S; McKendrick J; Lee B; Cho JH; Faragher I; Jones IT; Ptak J; Schaeffer MJ; Silliman N; Dobbyn L; Li L; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
JAMA Oncol; 2019 Dec; 5(12):1710-1717. PubMed ID: 31621801
[TBL] [Abstract][Full Text] [Related]
37. EFFECT OF SELECTED PROGNOSTIC AND RISK FACTORS ON SURVIVAL OF WOMEN WITH BREAST CANCER IN GEORGIA.
Vashakidze N; Mebonia N; Kereselidze M; Gvamichava R; Zhizhilashvili S
Georgian Med News; 2018 Jun; (279):23-28. PubMed ID: 30035717
[TBL] [Abstract][Full Text] [Related]
38. Association between waiting time for radiotherapy after surgery for early-stage breast cancer and survival outcomes in Ontario: a population-based outcomes study.
Raphael MJ; Saskin R; Singh S
Curr Oncol; 2020 Apr; 27(2):e216-e221. PubMed ID: 32489271
[TBL] [Abstract][Full Text] [Related]
39. Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: results from North Central Cancer Treatment Group adjuvant trial N9831.
Moreno-Aspitia A; Hillman DW; Dyar SH; Tenner KS; Gralow J; Kaufman PA; Davidson NE; Lafky JM; Reinholz MM; Lingle WL; Kutteh LA; Carney WP; Dueck AC; Perez EA
Cancer; 2013 Aug; 119(15):2675-82. PubMed ID: 23744760
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
